1 document found, page 1 of 1
Sort by
Issue Date
Nomogram for predicting survival after first-line anti-PD-1-based immunotherapy...
Chatziioannou, E.; Higuita, L. M. Serna; Kreft, S.; Kandolf, L.; Dujovic, B.; Reinhardt, L.; Tamara, E.; Marquez-Rodas, I.; Fortuna, A. R. F. P.Background: The introduction of anti-programmed cell death protein 1 (PD-1) immunotherapy has revolutionized the treatment landscape for melanoma, enhancing both response rates and survival outcomes in patients with advanced stages of the disease. Despite these remarkable advances, a noteworthy subset of patients (40%-60%) does not derive advantage from this therapeutic approach. This study aims to identify key...
Date: 2024
|
Origin: Sapientia - Universidade do Algarve